Golvatinib
Golvatinib Uses, Dosage, Side Effects, Food Interaction and all others data.
Golvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck.
| Trade Name | Golvatinib |
| Generic | Golvatinib |
| Golvatinib Other Names | Golvatinib |
| Type | |
| Formula | C33H37F2N7O4 |
| Weight | Average: 633.701 Monoisotopic: 633.287509025 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Golvatinib
